CVS Health (CVS) Tops Q3 EPS by 23c, Beats on Revenue; Offers FY25 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $80.97 -11.42%
Financial Fact:
Income from continuing operations: 1.54B
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Income from continuing operations: 1.54B
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q3 EPS of $1.60, $0.23 better than the analyst estimate of $1.37. Revenue for the quarter came in at $102.9 billion versus the consensus estimate of $98.88 billion.
GUIDANCE:
CVS Health sees FY2025 EPS of $6.55-$6.65, versus the consensus of $6.38.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Scotts Miracle-Gro (SMG) Tops Q4 EPS by 5c ; Offers Guidance
- CVS Health (CVS) Tops Q3 EPS by 44c, Beats on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
